# US 8,771,763 B2 · Composition for treating aids and associated conditions

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 8,771,763 B2
- Document ID: US8771763B2
- Status: Granted
- Kind: B2
- Application number: 13/949,613
- Filed: 2013-07-24
- Published: 2014-01-23
- Granted: 2014-07-08
- Earliest claimed: 2002-09-12
- Assignees: Wilfred-Ramix, Inc.
- Applicants: Wilfred-Ramix, Inc.
- Inventors: William Asiedu; Frederick Asiedu; Manny Ennin; Michael Nsiah Doudu; Charles Antwi Boateng; Kwasi Appiah-Kubi; Seth Opoku Ware; Debrah Boateng; Kofi Ampim; William Owusu; Akwete Lex Adjei
- Web page: https://patentgrep.com/patent/US8771763B2

## CPC

- A61K 36/185: Magnoliopsida (dicotyledons)
- A61K 36/00: Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines {(antigens from pollen A61K39/36)}
- A61K 36/21: Amaranthaceae (Amaranth family), e.g. pigweed, rockwort or globe amaranth
- A61K 36/22: Anacardiaceae (Sumac family), e.g. smoketree, sumac or poison oak
- A61K 36/24: Apocynaceae (Dogbane family), e.g. plumeria or periwinkle
- A61K 36/888: Araceae (Arum family), e.g. caladium, calla lily or skunk cabbage
- A61P 1/10: Laxatives
- A61P 11/00: Drugs for disorders of the respiratory system
- A61P 15/08: for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
- A61P 17/00: Drugs for dermatological disorders
- A61P 29/00: Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61P 31/06: for tuberculosis
- A61P 31/18: for HIV
- A61P 37/02: Immunomodulators
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

An Aids and associated conditions related to Aids treating compositions is disclosed. The compositions comprise: a medicament selected from an extract of at least one of the following plant families: Apocynaceae (Pleioscarpa Bicarpellata); Annonaceae (Cleistopholis Patens); Dichapetalaceae (Dichapetehan Madagasca Riense); Annoceae (Uvaristrum Pierreanum); Cynocynaceae (Strophantus Gratus); Asclepiadaceae (Gongronema Latifolium); Combretaceae (Combretum Racemosum); Apocynaceae (Alostonia Boonei); Amaranthaceae (Alternanthera Pungens); Aroceae (Anchomanes Differmis); Cyperaceae (Seleria Voivinil); Anacardiaceae (Lannea Acida); Bignodaceae (Kigelia Africana); Bombacaceae (Ceiba Pentanota); Anarcardiaceae (Antrocaryon Micraster); Bombacaceae (Bombax Bounopozense): Anarcardiaceae (Spondias Mombin); Caricaceae (Carica Papaya); a glyceryl ester of any of the foregoing extracts; a saponin of any of the foregoing extracts; an alkaloid of any of the foregoing extracts; a protein of any of the foregoing extracts; a fat of any of the foregoing extracts; a sugar of any of the foregoing extracts; and any mixture of any of the foregoing.

## Claims

### Claim 1

A composition for use in treating symptoms of AIDS patients, comprising a mixture of aqueous extracts from the following plants:
(a) Pleiocarpa bicarpellata, Alstonia boonei, or a mixture thereof;
(b) Alternanthera pungens;
(c) Anchomanes difformis;
(d) Scleria boivinii;
(e) Lannea acida, Antrocaryon micraster, Spondias mombin, or a mixture thereof; and
(f) Kigelia africana,
wherein the symptoms are one or both of: lack of appetite and immune dysfunction.

### Claim 2 (depends on 1)

The composition according to claim 1, wherein
(a) Pleiocarpa bicarpellata, Alstonia boonei, or a mixture thereof is present in the composition in an amount of 15 weight percent;
(b) Alternanthera pungens is present in the composition in an amount of 17 weight percent;
(c) Anchomanes difformis is present in the composition in an amount of 17 weight percent;
(d) Scleria boivinii is present in the composition in an amount of 17 weight percent;
(e) Lannea acida, Antrocaryon micraster, Spondias mombin, or a mixture thereof is present in the composition in an amount of 17 weight percent; and
(f) Kigelia africana is present in the composition in an amount of 17 weight percent,
wherein the mixture of extracts is further diluted with water to give a 0.5 to 25 weight percent extracts solution.